1. Introduction
The use of magnetic nanoparticles (MNPs) coupled with magnetic base devices has been increasing in the biomedical field [1,2,3,4]. Among them, superparamagnetic iron oxide nanoparticles (SPIONs) are widely used in nanomedicine for diagnoses, therapeutics, drug, and gene delivery systems [5,6,7,8]. To enhance SPION biocompatibility, solubility, and stability in physiological conditions, surface modifications with biocompatible polymers are necessary. Surface coating of SPIONs by dendrimers as three-dimensional (3D) hydrophilic polymers with highly branched macromolecular structures can increase their solubility in water by reducing their intermolecular attractions through an increase in steric hindrance [9,10]. Spatial structures of dendrimer-functionalized SPIONs (D-SPIONs), which are useful in conjugation with other chemicals and for encapsulation of drugs, serve as excellent imaging probes [11,12], such as for MRI, due to their prolonged half-life [13]. Moreover, the high colloidal stability and excellent biocompatibility of D-SPIONs are critical properties for MRI contrast media [14,15].
Recently, magnetic nanoparticle applications in ocular systems, such as corneal endothelial cell (CEC) migration and proliferation [16,17] under external magnetic forces, have received scholarly attention. In relevant studies, the CECs’ viability and morphology remained intact [16,18], and the cells’ metabolic activity was enhanced [19,20]. SPION-labeled CEC densities can be increased by using permanent magnets of different shapes and sizes. However, establishing a uniform distribution of CECs on the corneal surface remains challenging. We synthesized 20 nm SPIONs by using chemical decomposition methods. Four generations of dendrimers, namely poly(amidoamine) (PAMAM), were synthesized to functionalize SPIONs through divergent and convergent methods as stepwise chemical approaches. Functionalized SPIONs with dendrimers possess multiple amine groups in their surfaces for active connections involving biomolecule attachment. D-SPIONs can be used as MRI contrast media inside the ocular system for bioimaging. Furthermore, BCECs were exposed by D-SPIONs and manipulated under the tapping mode of two vertical electromagnets facing each other. Real time polymerase chain reaction was performed to assess the expression of genes in the BCECs treated with D-SPIONs, both under and not under a magnetic field. The simulation study confirmed that the uniform distribution of the BCECs under magnetic fields corresponds to the electromagnet’s displacement from the ocular surface. We believe that the interfacing between the magnetic fields and D-SPION-tagged BCECs can be further used as effective therapeutic tools for the ocular system.
2. Materials and Methods
2.1. Materials
Iron (III) acetylacetonate (Fe(acac)3), oleic acid, oleylamine, octyl ether, methyl acrylate, ethylenediamine, PBS, and dimethyl sulfoxide were purchased from Sigma Aldrich (Sigma Aldrich, St. Louis, MO, USA), and 3-aminopropyl triethoxysilane (APTES) was purchased from Merck (Merck & Co., Inc., Kenilworth, NJ, USA). PBS, and dimethyl sulfoxide.
2.1.1. Synthesis of SPIONs
The SPIONs were synthesized by thermal decomposition of the Fe(acac)3 inside a solution containing oleic acid, oleylamine, and octyl ether. The mixture was stirred for 30 min at room temperature under a nitrogen flow. Next, the temperature was increased to 300 °C for 1 h until the Fe(acac)3 had been completely decomposed. Finally, the solution was cooled to room temperature, washed several times with ethanol, and collected using permanent magnets [21].
2.1.2. D-SPIONs
The PAMAM-functionalized SPIONs were fabricated through three reaction steps, as described previously [22]. During the fabrication process, SPION surfaces should first be modified by amine group attachment for subsequent dendrimer coating. In brief, APTES in ethanol (10 mL, 10% vol/vol) was added dropwise to the SPIONs dispersed in ethanol through sonication. The mixture was stirred for 7 h, separated by magnets, washed with ethanol five times, and collected for further analysis. For the synthesis of the PAMAM-coated SPIONs, the methyl acrylate (15 mL, 20% vol/vol) was dissolved in methanol and added to the SPIONs functionalized with aminosilane (20 mL, 5% wt/vol) and stirred for 48 h. This was followed by 2 h of sonication. Next, the SPIONs were washed five times. Finally, ethylenediamine was dissolved in methanol (10 mL, 50% vol/vol), and added to the modified SPIONs, and the mixture was sonicated for 3 h. The resulting first-generation dendrimer on the SPION surface was then subjected to washing and purification using magnets. The two main reactions, involving the generation of ester bonds through the connection of methyl acrylate and amino silane in the first step and followed by the amidation of ester bonds with ethylenediamine in the second step, was repeated three times to fabricate the fourth-generation dendrimer branches (Figure 1).
2.2. Characterization Techniques
2.2.1. TEM, FTIR, XPS, Dynamic Light Scattering (DLS), and Zeta Potential
TEM was performed under an accelerating voltage of 200 kV. A field-emission Tecnai F20 electron gun of ZrO/W (100) Schottky type (resolution ≤0.23 nm) was used on a (Philips/FEI Corporation, Eindhoven, The Netherlands) TEM system. XPS was performed using an Al Kα X-ray source under a working energy of 1486.6 eV in a vacuum of approximately 10−7 Pa (XPS, ESCA000600). FTIR spectroscopy was conducted by grinding the SPIONs and D-SPIONs into powder with the KBr to make pellets using a Perkin Elmer system (PerkinElmer, Inc. Waltham, MA 02451 USA) in the range of 400–4000 cm−1. The DLS and zeta potential of the SPIONs and D-SPIONs dispersed in deionized water were measured using Malvern instrument (Malvern Panalytical Ltd, Great Malvern, UK).
2.2.2. Bovine Corneal Endothelial Cell Preparation
The bovine eyes were obtained from a local butchery and fumigated using an iodine solution [23]. After the eyes were washed with phosphate-buffered saline (PBS), the corneas were removed, as were the Descemet membranes. Subsequently, the Descemet membranes were incubated with trypsin under a CO2 atmosphere at 37 °C for 45 min until the cells were detached. After centrifugation at 1000 rpm for 5 min, the BCECs were collected and cultured.
2.2.3. MTT Cell Viability Assay
The 3-[4,5-dimethylthiazol-2yl]-2,5-diphenyl tetrazolium bromide (MTT) (Sigma Aldrich, St. Louis, MO, USA). viability assay of D-SPIONs was performed using bovine CECs (BCECs) for the duration of 24, 48, and 72 h. For the MTT assay, the 6 × 103 cells/well are cultured and grown on 96-well plates at 37 °C in an endothelial cell medium and 1% penicillin for 24 h. The cells were then incubated with five concentrations of D-SPIONs (10, 30, 50, 70, and 100 µg/mL) for 24, 48, and 72 h. At the end of the incubation periods, 10 μL of MTT was added to each well, and the cells were kept in the incubator for 3 h. Next, the cells were washed with PBS, 100 μL of dimethyl sulfoxide was added to each well, and the plate was shaken for 10 min. Finally, the optical density of each cell was determined at 595 nm on a microplate reader (Bio-Rad S/N 21648, Pleasanton, CA, USA) Using the absorbance data, the percentage of live cells was calculated [24,25].
2.2.4. MRI of Fourth-Generation D-SPIONs
To evaluate the MRI relaxivity of the fourth-generation D-SPIONs as T2-weighted contrast agents, a 7 Tesla Bruker BioSpec MRI system (Bruker BioS pec 70/30 US, Billerica, MA, USA) was used. T2-weighted relaxation times were defined by a multiecho spin-echo sequence (repetition time: 4000 ms; echo time
2.2.5. Electromagnet Setup
The electromagnet device consisted of two electromagnets facing each other under an up/down adjustable magnetic field gradient. The magnets were placed under a step functional magnetic field of approximately 500 G every 2 s and were triggered by using the Arduino device, delivering a step-functional ± 5 volts. The magnetic field consisted of two commercial electromagnets (Grove, seeed studio, Shenzhen, China) which were made by a thousand-rounds wire and a cold-rolled steel rod, and the working gap was tunable. The strength of the magnetic field was measured using a Tesla meter (TM-801 EXP, KANETEC) and was sensed at the bottom position of the dish [26].
After the BCECs were cultured and the number of cells reached the experimental requirements (104 BCECs in each 96-well plate), D-SPIONs (10 µg/mL) were added to the dish containing the cells and incubated for 24 h such that they could be absorbed by the cells. Finally, the BCECs were washed with PBS, and the D-SPION cells were placed under an applied magnetic field in an incubator for 1 month (Figure 6a).
2.2.6. BCEC Migration Assay
An in vitro BCEC scratch assay was performed. In brief, BCECs were seeded in a 96-well plate at a density of 104 cells/well and incubated for 24 h. Next, two concentrations of dendrimer coated iron oxide (1 and 10 μg/mL) were added to each well and incubated for 24 h at 37 °C under a CO2 atmosphere (untreated BCECs were used as controls). Next, straight lines are scratched in each well using a sterile 100 μL pipette tip. Images of the scratches in each well were examined at 100 × magnification under an inverted microscope and analyzed with ImageJ software. Each experiment was performed twice. The scratch experiments were repeated for the cell migration assay for the same concentrations under a magnetic field produced by electromagnets in tapping modes.
2.2.7. Simulation Study
A 3D simulation study was performed by COMSOL (COMSOL, Inc. Burlington, MA, USA), to confirm the distribution of the BCECs holding nanoparticles on the ocular surface. The uniform distribution of the CECs on the ocular surface is challenging for gene delivery and drug delivery toward the cornea. The delivery to CECs containing SPIONs was determined to be nonuniform, creating cell accumulations on the ocular surface. Herein, the density of the D-SPIONs was less than 1013 (1/m3); therefore, their contribution was ignored in the simulation. According to Maxwell’s equation, the magnetic flux density of the magnet can be expressed as:
(1)
where the μ0 denotes permeability, H is the magnetic field intensity, and M represents the magnetization.As presented in Figure 7, the cylindrical permanent magnet radius is labeled as rm, the distance between the magnet and the eyeball was denoted as D, and the eyeball radius was denoted as r. Physical properties of each item used in simulation are listed in Table 1.
2.2.8. Real-Time PCR Assay
Real-time PCR was performed according to the manufacturer’s protocol. The cDNA was synthesized using RNA, a random hexamer primer, Revert Aid Reverse Transcriptase, and a dNTP mix. The cDNA of the treated and untreated D-SPION cells were diluted using deionized water.
Real-time PCR was conducted using the Applied Biosystems 7500 Real-Time PCR System (Applied Biosystems, Foster City, CA, USA). The 20 μL container was filled with cDNA and the as prepared solution contained SYBR Green Real-Time PCR Master Mix, gene-specific primers, and deionized water. The gene-specific primers are listed in Table 2. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used to normalize the gene expression values, and melt curve analysis was conducted to assess the reaction specifications [27,28]. The 2−ΔΔCt method was employed to analyze the data. The cycle thresholds for the intrinsic control of GAPDH were derived from the cycle thresholds for all the cell markers. The fold changes for the D-SPION cells under a magnetic field were normalized to those of the untreated cells, and the values underwent an exponential linear conversion by using the 2−ΔΔCt equation [29].
2.2.9. Statistical Analysis
Analyses were conducted using SPSS software, and one-way analysis of variance was performed to find differences between SPIONs and D-SPIONs. A p-value of ≤0.05 was considered significant. Data are presented as ± standard errors of the mean.
3. Results and Discussion
3.1. Shape, Size, Surface Charge, and Structural Bonding of D-SPIONs
The shape, size, Surface charge, and structural bonding of D-SPIONs are shown in Figure 2.
3.1.1. TEM
TEM images of the D-SPIONs are presented in Figure 2a–c. The D-SPIONs were almost spherical and had a uniform size distribution. The D-SPIONs’ average size, as measured by applying ImageJ software to the TEM images, was approximately 20 ± 3 nm (Figure 2d).
3.1.2. FTIR
The attachment of the fourth-generation dendrimers on SPION surfaces was confirmed using Fourier transform infrared (FTIR) spectroscopy. As presented in Figure 2e, the sharp peak at 590 cm−1 was assigned to the Fe–O stretching vibration of the iron oxide nanoparticles at their tetrahedral site bond. As presented in the D-SPION spectra, the peaks at 1489 and 1567 cm−1 were attributed to the –CO–NH– groups, and the peak at 1023 cm−1 was ascribed to the –CO–NH2 groups, which are highly electronegative. Both peaks confirm the existence of the dendrimer branch on the SPION surfaces. Moreover, the peak at 3409 cm−1 was related to the –NH2-group vibration of the dendrimer [30]. Overall, the FTIR spectra indicate that the dendrimer modified the SPIONs.
3.1.3. XPS
Surface analysis of the SPIONs and D-SPIONs (G4) was performed using XPS (Figure 2f). The peak in the SPION spectra corresponded to the C1s (285 eV), O1s (528.5 eV), and Fe2p (710.3 eV). In the D-SPION spectra, a peak corresponding to the nitrogen sign at N1s (398.2 eV) was observed [2]. XPS analysis revealed the presence of the dendrimer on the iron oxide nanoparticle surfaces. The peak position of N1s, which appeared at 390–400 eV, confirmed that the dendrimer molecules were attached to the iron oxide surfaces [31]. The SPION peak Fe2p and the oxygen peak O1s exhibit a reduction in their intensity by covering the SPIONs with the PAMAM layers, but the amount of the carbon (C1s) atoms is increased, and the nitrogen peaks appear in the D-SPION spectra. The increase in dendrimer layers at the SPION surface reduces the amount of the iron and oxygen molecules through a process wherein the dendrimer thickness is increased [32].
3.1.4. DLS and Zeta Potential
The hydrodynamic size of SPIONs and the fourth-generation D-SPIONs were measured using DLS. As shown in Figure 2g, the hydrodynamic size of the SPIONs was increased after they were coated with the dendrimer. The hydrodynamic diameter of the SPIONs and D-SPIONs exceed the actual sizes seen in the TEM images; this inaccuracy is the main disadvantage of using DLS. In DLS, signals from larger particles can suppress signals from smaller particles, and it could be associated with the higher contribution of the light scattering to the nanoparticle size distributions. This means that higher size distributions can lead to errors in DLS size measurements, yielding discrepancies with the real size indicated in TEM. Furthermore, for highly magnetic nanoparticles, nanoparticle agglomeration occurs during measurement, which can affect the analytical signals. The surface charge study of SPIONs and D-SPIONs, as performed through zeta potential measurement, was −24 and −0.6 mV, respectively. These results can be attributed to the carboxylate moiety on the SPION surface. This surface is further functionalized by the amine groups of PAMAM producing D-SPIONs [33].
3.2. MTT Cytotoxicity Assay
The 3-[4,5-dimethylthiazol-2yl]-2,5-diphenyl tetrazolium bromide (MTT) cytotoxicity assay to investigate the cytotoxicity of five concentrations of D-SPIONs under 24, 48, and 72 h of treatment on BCECs (Figure 3). The BCECs exhibited various biological responses when exposed to differing dosages of D-SPIONs over varying durations. No significant toxicity of D-SPIONs on BCECs was noted up to 100 μg/mL for 24 h. The cell viability for the 100 μg/mL under 48 and 72 h of incubation was 68% and 65%, respectively. Because iron oxide nanoparticles are biocompatible and nontoxic, they display slight cytotoxicity against BCECs [28,34].
3.3. MRI of D-SPIONs
Figure 4 presents the MRI images of the D-SPIONs specifically, T2 images at various sample concentrations (Figure 4a) and relaxation rates against various sample concentrations (Figure 4b). Dose dependence was noted, as indicated by the darkening that occurred as the spin–spin relaxation time (T2) was shortened. The transverse relaxation rate (1/T2) versus the various concentrations of the D-SPIONs is presented in a linear plot [35]. The relaxivity r2 was calculated to be 46 mM−1S−1.The SPIONs and D-SPIONs were reported to enhance the transverse relaxation rate more than the longitudinal relaxation rate and be a negative contrast agent. Dendrimer-based MRI contrast agents has also been used for imaging brain tumors [36]. As synthetic macromolecules, dendrimers can improve the relaxivity in MRI because of their 3D structures, tunable sizes, and abundant surface terminals. Furthermore, they can increase the positivity of iron oxide. Coating dendrimers on the SPION surface promote their specific targeting, enhance MRI image quality, reduce their toxicity on cells, and allow for safe in vivo imaging.
3.4. Cell Migration Assay under Magnetic Fields
Migration in CECs is an essential step in the wound healing process. Cell migration was suppressed in the BCECs treated with D-SPIONs compared with in the control cells (BCECs without nanoparticles). Moreover, the migration of the BCECs containing 1 μg/mL D-SPIONs was faster than that of the cells containing 10 μg/mL SPIONs (Figure 5). Increases in nanoparticle agglomeration, cell uptake capacities, and nanoparticle moieties on the cell surfaces are the main reasons for the delay in cell migration under increases in the D-SPION concentration [37]. Under a magnetic field produced by electromagnets in tapping mode, wound closure in the BCECs treated with 1 μg/mL SPIONs took 10 h. This is even faster than wound closure in the control BCECs. Notably, the magnetic vortex patterns were created by BCECs containing D-SPIONs by applying the magnetic field for both concentrations of D-SPIONs (1 and 10 μg/mL) at different times (Figure 6b) [38].
3.5. COMSOL Multiphysics Simulation Study
In the simulation, we assumed no current conveyance in the domain (H = 0); next, the magnetic flux density was adjusted through the magnet. The magnetization was calculated to be 104 (A/m) in the z direction from the electromagnet under a rm of 0.8r and a D of 0.2r. Table 1 lists the other parameters. The magnetic flux density created on the ocular surface was inversely proportional to the magnet’s displacement from the ocular surface (Figure 7). When the displacement was increased, the magnetic flux density decreased, affecting the number of magnetic patterns on the ocular surface. In this regard, the isometric line vortex around the magnetization direction was considered.
3.6. Real-Time PCR
To investigate the change in the cellular identity of the BCECs before and after the treatments with the alternative magnetic field, real-time PCR was conducted (Figure 8). To measure the mRNA expression of specific genes, BCEC-specific markers (ATP1A1, CDH2, ENO2, NCAM1, SLC4A4, and zonula occludens-1 [ZO-1]), were used for untreated cells and treated cells for 1 month [39,40]. The markers were selected based on strong expression of genes in BCECs, and low expression of them in stromal cells. Comparison of the gene expression of D-SPION endothelial cells before and after 1-month cell treatment revealed an approximate sixfold growth in ATP1A1 and NCAM1 expression and an approximate 2.5-fold growth in ENO2 and SLC4A4. No major changes were observed in ZO-1 and CDH2 expression; moreover, no clear differences in the tight junction morphology of the BCECs before and after the treatments (ZO-1 is a protein involved in cellular function). The significantly high increase in adenine triphosphatase (ATPase)Na+/K+ transporting α1polypeptide (ATP1A1) was reported. ATP1A1 supplies instructions for fabricating the alpha-1 subunit of a Na+/K+ ATPase, which is known as a protein pump. ATP is then used by the protein to transport K+ ions into and Na+ ions out of cells [41]. The solute carrier 4 SLC4 transporters (except SLC4A11) are divided into three groups based on their functions: anion exchangers, sodium bicarbonate cotransporters (NBCs), and sodium-driven Cl–/HCO– exchangers [42,43]. Next, the expression of SLC4A4 as an electrogenic NBC1 was localized in the basolateral membrane of corneal epithelial cells. The expression of the SLC4A4 gene (as a primary member in the corneal endothelium) suggests that NBCs are the main bicarbonate transporters in the corneal endothelium. Moreover, for the SLC4A4 gene upregulated, the increase of salt content in the medium after magnetic treatments could increase the expression of solute transporter [44]. The expression of the neural cell adhesion molecule, which is encoded by the NCM1 gene, was significantly increased. NCM, an adhesion molecule known as the immunoglobulin gene [45], can interface neuron-muscular and neuron–neuron adhesion through their interactions and initiate cell matrix interactions. NCAM expression by HCECs has a neural crest origin. NCAM overexpression might correspond to the adhesion of the BCECs to each other.
4. Conclusions
The SPION surfaces were functionalized with the fourth-generation dendrimer for better spatial distance. The TEM images revealed that the D-SPIONs measured approximately 20 nm. FTIR spectroscopy and XPS confirmed the coating of the dendrimer on the SPION surfaces. The zeta potential of the SPIONs changed from approximately −28 to −0.6 mV after dendrimer functionalization because of the induction of amine groups on its surfaces. The MTT assay indicated that the D-SPION had low toxicity on the BCECs over 24 h. Moreover, the coated nanoparticles could be used as contrast agents for in vivo bioimaging. The cell migration assay showed fast migration within 10 h of treatment with 1 μg/mL D-SPIONs under magnetic fields, as well as a uniform distribution of BCEC-containing D-SPIONs. These vortex pattern of BCECs containing D-SPIONs was simulated using COMSOL Multiphysics software for in vivo applications. The real time-PCR results for BCECs treated with D-SPIONs under magnetic fields indicated the overexpression of the AT1P1 and NCAM1 genes, which could explain the rapid wound closure in migration assay.
S.H. designed the project, performed the study, and wrote the manuscript; P.-J.S. supervised the study, and helped acquire funding; B.-W.C. contributed to nanoparticles synthesis and characterization; thanks H.-J.S. did the simulation study; I.-J.W. and T.-H.Y. were principal investigators and helped acquire funding; and D.-J.Y. helped acquire funding contributed to nanoparticles characterization. All authors have read and approved the final version of the manuscript.
This work was supported by Taiwan’s Ministry of Science and Technology under grant numbers MOST 106-2314-13-002-124-MY3 and MOST 107-2221-E-002-194-MY3. It was also supported by the Excellent Translational Medicine Research Projects of National Taiwan University College of Medicine and National Taiwan University Hospital under grant number NSCCMOH-131-72.
Not applicable.
Not applicable.
The data presented in this study are available on request from the corresponding author.
The authors declare no conflict of interest.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figure 1. Process of fourth-generation dendrimer functionalization of the SPION surfaces.
Figure 2. Shows the (a–c) TEM images of the D-SPIONs; (d) size distribution histogram of D-SPIONs; (e) FTIR spectra; (f) XPS survey patterns; (g) DLS of the SPIONs and D-SPIONs.
Figure 3. Cell viability MTT assay for varying concentrations of D-SPIONs on BCECs over 24, 48, and 72 h. Data are presented as means ± standard deviations (n = 3). One-way analysis of variance and the Tukey post hoc test revealed no significant difference based on the different incubation times (p > 0.05).
Figure 4. (a) T2-weighted magnetic resonance images at six D-SPION concentrations; (b) linear fitting of relaxation rate (1/T2) versus D-SPION concentrations. The relaxivity values of r2 were calculated from the slope of the graph.
Figure 5. Migration assay of BCECs treated under varying concentrations of D-SPIONs over 16 and 24 h.
Figure 6. (a) The magnetic device used in this experiment; (b) cell migration assay of BCECs containing different concentrations of D-SPIONs under a gradient magnetic field.
Figure 7. Magnetic flux density versus the electromagnet’s displacement from the ocular surface.
Figure 8. Gene expression level of BCECs incubated with D-SPIONs and treated with an electromagnet system using real time PCR. The genes were normalized using GAPDH. The cells incubated with the MNPs were used as the control group and statistically differences were (p < 0.05; n = 3). Data are presented as the means standard deviations of three experiments.
Physical properties of each item included in the simulation.
Items | Electrical Conductivity | Relative Permittivity | Relative Permeability |
---|---|---|---|
Eye ball | 0.05 | 83 | 0.999992 |
Air | 0.01 | 1 | 1.00000037 |
Magnet | 1 | 1 |
Primers used in this study.
Gene | Gene Sequence |
---|---|
ATP1A1 FW | 5′-CAAGCCCTCGTGATTCGAAA-3′ |
ATP1A1 REV | 5′-TCCACCTTGCAGCCATTT-G-3′ |
ENO2 FW | 5′-TGA-CAA-GGC-TGG-CTA-CAC-AGA-3′ |
ENO2 REV | 5′-CAT-ATT-TGC-CAT-CGC-GGT-AA-3′ |
ZO1 FW | 5′-TTC GAT TGG CCA GCCATA TAT-3′ |
ZO1 REV | 5′-TGT TTTCCGTCA CGG TAC CA-3′ |
NCAM1FW | 5′-CGGATCTCGGTGGTATGGAA-3′ |
NCAM1REV | 5′-CCGCAGTGACCACACACTTG-3′ |
SLC4A4FW | 5′-GTGCTTGTTGGCGAGGTAGAC-3′ |
SLC4A4 REV | 5′-GGACTTGGCTTTCCCCTTAGG-3′ |
CDH2 FW | 5′-AGCAGTAAAACTGAGCCTCAAACC-3′ |
CDH2 REV | 5′-TGC CTC TGC AGG TAG CCA TT-3′ |
GAPDH FW | 5′-AGGGTCATCATCTCTGCACCTT-3′ |
GAPDH REV | 5′-TGGTCATAAGTCCCTCCAACGG-3′ |
References
1. Hatamie, S.; Parseh, B.; Ahadian, M.M.; Naghdabadi, F.; Saber, R.; Soleimani, M. Heat transfer of PEGylated cobalt ferrite nanofluids for magnetic fluid hyperthermia therapy: In vitro cellular study. J. Magn. Magn. Mater.; 2018; 462, pp. 185-194. [DOI: https://dx.doi.org/10.1016/j.jmmm.2018.05.020]
2. Hatamie, S.; Shih, P.J.; Soufi Zomorod, M.; Heravi, P.; Ahadian, M.M.; Hatami, N. Hyperthermia response of PEGylated magnetic graphene nanocomposites for heating applications and accelerate antibacterial activity using magnetic fluid hyperthermia. Appl. Phys. A Mater. Sci. Process.; 2020; 126, 276. [DOI: https://dx.doi.org/10.1007/s00339-020-3454-3]
3. Fardindoost, S.; Hatamie, S.; Zad, A.I.; Astaraei, F.R. Hydrogen sensing properties of nanocomposite graphene oxide/Co-based metal organic frameworks (Co-MOFs@GO). Nanotechnology; 2018; 29, 015501. [DOI: https://dx.doi.org/10.1088/1361-6528/aa9829]
4. Farzaneh, S.; Hosseinzadeh, S.; Samanipour, R.; Hatamie, S.; Ranjbari, J.; Khojasteh, A. Fabrication and characterization of cobalt ferrite magnetic hydrogel combined with static magnetic field as a potential bio-composite for bone tissue engineering. J. Drug Deliv. Sci. Technol.; 2021; 64, 102525. [DOI: https://dx.doi.org/10.1016/j.jddst.2021.102525]
5. Chen, B.-W.; Hatamie, S.; Garu, P.; Heravi, P.; Chen, J.-Y.; Liu, B.-T.; Wei, Z.-H.; Yao, D.-J. Synthesis of iron-oxide magnetic nanoparticles coated with dextran of varied molecular mass using a facile ball-milling method. Micro Nano Lett.; 2020; 15, pp. 645-650. [DOI: https://dx.doi.org/10.1049/mnl.2019.0811]
6. Bani, M.S.; Hatamie, S.; Haghpanahi, M.; Bahreinizad, H.; Alavijeh, M.H.S.; Eivazzadeh-Keihan, R.; Wei, Z.H. Casein-Coated Iron Oxide Nanoparticles for in vitro Hyperthermia for Cancer Therapy. SPIN; 2019; 9, pp. 1-10. [DOI: https://dx.doi.org/10.1142/S2010324719400034]
7. Bani, M.S.; Hatamie, S.; Haghpanahi, M. Biocompatibility and hyperthermia cancer therapy of casein-coated iron oxide nanoparticles in mice. Polym. Adv. Technol.; 2020; 31, pp. 1544-1552. [DOI: https://dx.doi.org/10.1002/pat.4883]
8. Talebi, M.; Balasi, Z.M.; Ahadian, M.M.; Hatamie, S.; Alavijeh, M.H.S.; Ghafuri, H. Biocompatibility and Hyperthermia Efficiency of Sonochemically Synthesized Magnetic Nanoparticles. Spin; 2019; 9, 1940006. [DOI: https://dx.doi.org/10.1142/S201032471940006X]
9. Alavijeh, M.S.; Bani, M.S.; Rad, I.; Hatamie, S.; Zomorod, M.S.; Haghpanahi, M. Antibacterial properties of ferrimagnetic and superparamagnetic nanoparticles: A comparative study. J. Mech. Sci. Technol.; 2021; 35, pp. 815-821. [DOI: https://dx.doi.org/10.1007/s12206-021-0143-x]
10. Taheri-Kafrani, A.; Shirzadfar, H.; Tavassoli-Kafrani, E. Dendrimers and Dendrimers-Grafted Superparamagnetic Iron Oxide Nanoparticles: Synthesis, Characterization, Functionalization, and Biological Applications in Drug Delivery Systems; Elsevier: Amsterdam, The Netherlands, 2017; ISBN 9780323527279
11. Lancina, M.G.; Singh, S.; Kompella, U.B.; Husain, S.; Yang, H. Fast Dissolving Dendrimer Nanofiber Mats as Alternative to Eye Drops for More Efficient Antiglaucoma Drug Delivery. ACS Biomater. Sci. Eng.; 2017; 3, pp. 1861-1868. [DOI: https://dx.doi.org/10.1021/acsbiomaterials.7b00319]
12. Jeong‡, Y.; Kim‡, S.T.; Jiang, Y.; Duncan, B.; Kim, C.S.; Saha, K.; Yeh, Y.-C.; Yan, B.; Tang, R.; Hou, S. et al. Nanoparticle–dendrimer hybrid nanocapsules for therapeutic delivery. Nanomedicine; 2016; 11, pp. 1571-1578. [DOI: https://dx.doi.org/10.2217/nnm-2016-0034] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/27175480]
13. Ding, L.; Lyu, Z.; Dhumal, D.; Kao, C.L.; Bernard, M.; Peng, L. Dendrimer-based magnetic resonance imaging agents for brain cancer. Sci. China Mater.; 2018; 61, pp. 1420-1443. [DOI: https://dx.doi.org/10.1007/s40843-018-9323-6]
14. Soleymani, M.; Velashjerdi, M.; Shaterabadi, Z.; Barati, A. One-pot preparation of hyaluronic acid-coated iron oxide nanoparticles for magnetic hyperthermia therapy and targeting CD44-overexpressing cancer cells. Carbohydr. Polym.; 2020; 237, 116130. [DOI: https://dx.doi.org/10.1016/j.carbpol.2020.116130]
15. Wang, K.; An, L.; Tian, Q.; Lin, J.; Yang, S. Gadolinium-labelled iron/iron oxide core/shell nanoparticles as T1–T2 contrast agent for magnetic resonance imaging. RSC Adv.; 2018; 8, pp. 26764-26770. [DOI: https://dx.doi.org/10.1039/C8RA04530E]
16. Wang, T.J.; Wang, I.J.; Hu, F.R.; Young, T.H. Applications of biomaterials in corneal endothelial tissue engineering. Cornea; 2016; 35, pp. S25-S30. [DOI: https://dx.doi.org/10.1097/ICO.0000000000000992]
17. Cornell, L.E.; Wehmeyer, J.L.; Johnson, A.J.; Desilva, M.N.; Zamora, D.O. Magnetic Nanoparticles as a Potential Vehicle for Corneal Endothelium Repair. Mil. Med.; 2016; 181, pp. 232-239. [DOI: https://dx.doi.org/10.7205/MILMED-D-15-00151]
18. Zhu, Q.; Zhu, Y.; Tighe, S.; Liu, Y.; Hu, M. Engineering of human corneal endothelial cells in vitro. Int. J. Med. Sci.; 2019; 16, pp. 507-512. [DOI: https://dx.doi.org/10.7150/ijms.30759]
19. Moysidis, S.N.; Alvarez-Delfin, K.; Peschansky, V.J.; Salero, E.; Weisman, A.D.; Bartakova, A.; Raffa, G.A.; Merkhofer, R.; Kador, K.E.; Kunzevitzky, N.J. et al. Magnetic field-guided cell delivery with nanoparticle-loaded human corneal endothelial cells. Nanomed. Nanotechnol. Biol. Med.; 2015; 11, pp. 499-509. [DOI: https://dx.doi.org/10.1016/j.nano.2014.12.002]
20. Alavijeh, M.S.; Maghsoudpour, A.; Khayat, M. Cobalt ferrite decoration of molybdenum disulfide nanosheets; development of a nanocomposite-mediated hyperthermia method. J. Mech. Sci. Technol.; 2021; 35, pp. 1319-1325. [DOI: https://dx.doi.org/10.1007/s12206-020-1242-9]
21. Heidari Majd, M.; Asgari, D.; Barar, J.; Valizadeh, H.; Kafil, V.; Abadpour, A.; Moumivand, E.; Mojarrad, J.S.; Rashidi, M.R.; Coukos, G. et al. Tamoxifen loaded folic acid armed PEGylated magnetic nanoparticles for targeted imaging and therapy of cancer. Colloids Surf. B Biointerfaces; 2013; 106, pp. 117-125. [DOI: https://dx.doi.org/10.1016/j.colsurfb.2013.01.051] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23434700]
22. Khodadust, R.; Unsoy, G.; Yalcin, S.; Gunduz, G.; Gunduz, U. PAMAM dendrimer-coated iron oxide nanoparticles: Synthesis and characterization of different generations. J. Nanoparticle Res.; 2013; 15, 1488. [DOI: https://dx.doi.org/10.1007/s11051-013-1488-6]
23. Ho, W.T.; Chang, J.S.; Chou, S.F.; Hwang, W.L.; Shih, P.J.; Chang, S.W.; Yang, M.H.; Jou, T.S.; Wang, I.J. Targeting non-muscle myosin II promotes corneal endothelial migration through regulating lamellipodial dynamics. J. Mol. Med.; 2019; 97, pp. 1345-1357. [DOI: https://dx.doi.org/10.1007/s00109-019-01818-5]
24. Mahmoudifard, M.; Soudi, S.; Soleimani, M.; Hosseinzadeh, S.; Esmaeili, E.; Vossoughi, M. Efficient protein immobilization on polyethersolfone electrospun nanofibrous membrane via covalent binding for biosensing applications. Mater. Sci. Eng. C; 2016; 58, pp. 586-594. [DOI: https://dx.doi.org/10.1016/j.msec.2015.09.007] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26478348]
25. Hatamie, S.; Ahadian, M.M.; Soufi Zomorod, M.; Torabi, S.; Babaie, A.; Hosseinzadeh, S.; Soleimani, M.; Hatami, N.; Wei, Z.H. Antibacterial properties of nanoporous graphene oxide/cobalt metal organic framework. Mater. Sci. Eng. C; 2019; 104, 109862. [DOI: https://dx.doi.org/10.1016/j.msec.2019.109862]
26. Hatamie, S.; Mohamadyar-Toupkanlou, F.; Mirzaei, S.; Ahadian, M.M.; Hosseinzadeh, S.; Soleimani, M.; Wei, Z.H.; Hsieh, T.-F.; Chang, W.-C.; Wang, C.-L. Cellulose acetate/magnetic graphene nanofiber is enhanced human mesenchymal stem cells osteogenic differentiation under alternative current magnetic field. Spin; 2019; 9, 1940011. [DOI: https://dx.doi.org/10.1142/S2010324719400113]
27. Mahsa, S.; Hatamie, S.; Naderi, A.; Parivar, K. Reduced graphene oxide/nanohydroxy Apatite-Bismuth nanocomposites for osteogenic differentiation of human mesenchymal stem cells. Asian J. Nanosci. Orginal Res.; 2020; 3, pp. 330-339. [DOI: https://dx.doi.org/10.26655/AJNANOMAT.2020.4.7]
28. Nazari, H.; Heirani-Tabasi, A.; Hajiabbas, M.; Khalili, M.; Shahsavari Alavijeh, M.; Hatamie, S.; Mahdavi Gorabi, A.; Esmaeili, E.; Ahmadi Tafti, S.H. Incorporation of two-dimensional nanomaterials into silk fibroin nanofibers for cardiac tissue engineering. Polym. Adv. Technol.; 2020; 31, pp. 248-259. [DOI: https://dx.doi.org/10.1002/pat.4765]
29. Hekmat, A.; Hatamie, S.; Bakhshi, E. Probing the effects of synthesized silver nanowire/reduced graphene oxide composites on the structure and esterase-like activity of human serum albumin and its impacts on human endometrial stem cells: A new platform in nanomedicine. Nanomed. J.; 2021; 8, pp. 42-56.
30. Nigam, S.; Bahadur, D. Dendrimer-conjugated iron oxide nanoparticles as stimuli-responsive drug carriers for thermally-activated chemotherapy of cancer. Colloids Surf. B Biointerfaces; 2017; 155, pp. 182-192. [DOI: https://dx.doi.org/10.1016/j.colsurfb.2017.04.025]
31. Jędrzak, A.; Grześkowiak, B.F.; Coy, E.; Wojnarowicz, J.; Szutkowski, K.; Jurga, S.; Jesionowski, T.; Mrówczyński, R. Dendrimer based theranostic nanostructures for combined chemo- and photothermal therapy of liver cancer cells in vitro. Colloids Surf. B Biointerfaces; 2019; 173, pp. 698-708. [DOI: https://dx.doi.org/10.1016/j.colsurfb.2018.10.045]
32. Daniel, P.; Shylin, S.I.; Lu, H.; Tahir, M.N.; Panthöfer, M.; Weidner, T.; Möller, A.; Ksenofontov, V.; Tremel, W. The surface chemistry of iron oxide nanocrystals: Surface reduction of γ-Fe2O3 to Fe3O4 by redox-active catechol surface ligands. J. Mater. Chem. C; 2018; 6, pp. 326-333. [DOI: https://dx.doi.org/10.1039/C7TC04795A]
33. Esmaeili, E.; Khalili, M.; Sohi, A.N.; Hosseinzadeh, S.; Taheri, B.; Soleimani, M. Dendrimer functionalized magnetic nanoparticles as a promising platform for localized hyperthermia and magnetic resonance imaging diagnosis. J. Cell. Physiol.; 2019; 234, pp. 12615-12624. [DOI: https://dx.doi.org/10.1002/jcp.27849]
34. Nazari, H.; Azadi, S.; Hatamie, S.; Zomorrod, M.S.; Ashtari, K.; Soleimani, M.; Hosseinzadeh, S. Fabrication of graphene-silver/polyurethane nanofibrous scaffolds for cardiac tissue engineering. Polym. Adv. Technol.; 2019; 30, pp. 2086-2099. [DOI: https://dx.doi.org/10.1002/pat.4641]
35. Hatamie, S.; Balasi, Z.M.; Ahadian, M.M.; Mortezazadeh, T.; Shams, F.; Hosseinzadeh, S. Hyperthermia of breast cancer tumor using graphene oxide-cobalt ferrite magnetic nanoparticles in mice. J. Drug Deliv. Sci. Technol.; 2021; 65, 102680. [DOI: https://dx.doi.org/10.1016/j.jddst.2021.102680]
36. Hatamie, S.; Ahadian, M.M.; Ghiass, M.A.; Iraji zad, A.; Saber, R.; Parseh, B.; Oghabian, M.A.; Shanehsazzadeh Zadeh, S. Graphene/cobalt nanocarrier for hyperthermia therapy and MRI diagnosis. Colloids Surf. B Biointerfaces; 2016; 146, pp. 271-279. [DOI: https://dx.doi.org/10.1016/j.colsurfb.2016.06.018]
37. Hatamie, S.; Shih, P.-J.; Chen, B.-W.; Wang, I.-J.; Young, T.-H.; Yao, D.-J. Synergic Effect of Novel WS2 Carriers Holding Spherical Cobalt Ferrite @cubic Fe3O4 (WS2/s-CoFe2O4@c-Fe3O4) Nanocomposites in Magnetic Resonance Imaging and Photothermal Therapy for Ocular Treatments and Investigation of Corneal Endothelial Cell Migration. Nanomaterials; 2020; 10, 2555. [DOI: https://dx.doi.org/10.3390/nano10122555] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/33352770]
38. Stern, M.; Cohen, M.; Danielli, A. Configuration and design of electromagnets for rapid and precise manipulation of magnetic beads in biosensing applications. Micromachines; 2019; 10, 784. [DOI: https://dx.doi.org/10.3390/mi10110784]
39. Demirci, H.; Slimani, N.; Pawar, M.; Kumon, R.E.; Vaishnava, P.; Besirli, C.G. Magnetic hyperthermia in Y79 retinoblastoma and ARPE- 19 retinal epithelial cells: Tumor selective apoptotic activity of iron oxide nanoparticle. Transl. Vis. Sci. Technol.; 2019; 8, 18. [DOI: https://dx.doi.org/10.1167/tvst.8.5.18] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31602343]
40. Tabatabaei, S.N.; Derbali, R.M.; Yang, C.; Superstein, R.; Hamel, P.; Chain, J.L.; Hardy, P. Co-delivery of miR-181a and melphalan by lipid nanoparticles for treatment of seeded retinoblastoma. J. Control. Release; 2019; 298, pp. 177-185. [DOI: https://dx.doi.org/10.1016/j.jconrel.2019.02.014]
41. Young, T.H.; Wang, I.J.; Hu, F.R.; Wang, T.J. Fabrication of a bioengineered corneal endothelial cell sheet using chitosan/polycaprolactone blend membranes. Colloids Surf. B Biointerfaces; 2014; 116, pp. 403-410. [DOI: https://dx.doi.org/10.1016/j.colsurfb.2014.01.024]
42. Dahlin, A.; Geier, E.; Stocker, S.L.; Cropp, C.D.; Grigorenko, E.; Bloomer, M.; Siegenthaler, J.; Xu, L.; Basile, A.S.; Tang-Liu, D.D.S. et al. Gene expression profiling of transporters in the solute carrier and ATP-binding cassette superfamilies in human eye substructures. Mol. Pharm.; 2013; 10, pp. 650-663. [DOI: https://dx.doi.org/10.1021/mp300429e]
43. Kadam, R.S.; Ramamoorthy, P.; Laflamme, D.J.; McKinsey, T.A.; Kompella, U.B. Hypoxia alters ocular drug transporter expression and activity in rat and calf models: Implications for drug delivery. Mol. Pharm.; 2013; 10, pp. 2350-2361. [DOI: https://dx.doi.org/10.1021/mp3007133] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23607566]
44. Shei, W.; Liu, J.; Htoon, H.M.; Aung, T.; Vithana, E.N. Differential expression of the Slc4 bicarbonate transporter family in murine corneal endothelium and cell culture. Mol. Vis.; 2013; 19, pp. 1096-1106. [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23734078]
45. Foets, B.J.J.; van den Oord, J.J.; Volpes, R.; Missotten, L. In situ immunohistochemical analysis of cell adhesion molecules on human corneal endothelial cells. Br. J. Ophthalmol.; 1992; 76, pp. 205-209. [DOI: https://dx.doi.org/10.1136/bjo.76.4.205] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/1382576]
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
To improve bovine corneal endothelial cell (BCEC) migration, enhance cell energy, and facilitate symmetric cell distribution in corneal surfaces, an electromagnet device was fabricated. Twenty nanometer superparamagnetic iron oxide nanoparticles (SPIONs) functionalized with fourth-generation dendrimer macromolecules were synthesized, and their size and structure were evaluated using transmission electron microscopy (TEM), X-ray photoelectron spectroscopy (XPS), and Fourier transform infrared spectroscopy (FTIR). The results confirmed the configuration of the dendrimer on the SPION surfaces. In vitro biocompatibility was assessed using the 3-[4,5-dimethylthiazol-2yl]-2,5-diphenyl tetrazolium bromide assay. No significant toxicity was noted on BCECs within 24 h of incubation. In the cell migration assay, cells treated with dendrimer-coated SPIONs exhibited a relatively high wound healing rate under sample addition (1 μg/mL) under a magnetic field. Real-time PCR on BCECs treated with dendrimer-coated SPIONs revealed upregulation of specific genes, including AT1P1 and NCAM1, for BCECs-dendrimer-coated SPIONs under a magnetic field. The three-dimensional dispersion of BCECs containing dendrimer-coated SPIONs under a magnetic field was evaluated using COMSOL Multiphysics software. The results revealed the BCECs-SPION vortex pattern layers in the corneal surface corresponded to the electromagnet’s displacement from the ocular surface. Magnetic resonance imaging (MRI) indicated that dendrimer-coated SPIONs can be used as a T2 contrast agent.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 College of Medicine, National Taiwan University, Taipei 10048, Taiwan;
2 Department of Biomedical Engineering, National Taiwan University, Taipei 10617, Taiwan;
3 Institute of Nanoengineering and Microsystem, National Tsing Hua University, Hsinchu 30013, Taiwan;
4 Institute of Applied Mechanics, National Taiwan University, Taipei 10617, Taiwan;
5 College of Medicine, National Taiwan University, Taipei 10048, Taiwan;